Literature DB >> 22061863

A novel splicing mutation in FKBP10 causing osteogenesis imperfecta with a possible mineralization defect.

Giacomo Venturi1, Elena Monti, Luca Dalle Carbonare, Massimiliano Corradi, Alberto Gandini, Maria Teresa Valenti, Attilio Boner, Franco Antoniazzi.   

Abstract

Osteogenesis imperfecta (OI) is a group of hereditary disorders characterized by bone fragility and osteopenia, with a broad spectrum of clinical severity. The majority of cases are dominantly inherited and due to mutations in type I collagen genes, whereas recessive forms are less frequent and attributable to mutations in different genes involved in collagen I post translational modifications and folding (prolyl-3-hydroxylase complex, SERPINH1, FKBP10). We report the case of a patient with an initially mild and then progressively severe form of osteogenesis imperfecta due to a novel homozygous splicing mutation in FKBP10 (intron 8 c.1399+1G>A), which results in aberrant mRNA processing and consequent lack of FKBP65 chaperone. Although this mutation does not affect collagen type I post translational modifications in dermal fibroblasts, the histomorphometric pattern of our patient's bone sample showed a mineralization defect possibly due to the mutation in FKBP10.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22061863     DOI: 10.1016/j.bone.2011.10.023

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  14 in total

1.  Novel Deletion of SERPINF1 Causes Autosomal Recessive Osteogenesis Imperfecta Type VI in Two Brazilian Families.

Authors:  Renata Moldenhauer Minillo; Nara Sobreira; Maria de Fatima de Faria Soares; Julie Jurgens; Hua Ling; Kurt N Hetrick; Kimberly F Doheny; David Valle; Decio Brunoni; Ana B Alvarez Perez
Journal:  Mol Syndromol       Date:  2014-11-25

2.  FKBP10 depletion enhances glucocerebrosidase proteostasis in Gaucher disease fibroblasts.

Authors:  Derrick Sek Tong Ong; Ya-Juan Wang; Yun Lei Tan; John R Yates; Ting-Wei Mu; Jeffery W Kelly
Journal:  Chem Biol       Date:  2013-02-21

3.  A substrate preference for the rough endoplasmic reticulum resident protein FKBP22 during collagen biosynthesis.

Authors:  Yoshihiro Ishikawa; Hans Peter Bächinger
Journal:  J Biol Chem       Date:  2014-05-12       Impact factor: 5.157

4.  Absence of FKBP10 in recessive type XI osteogenesis imperfecta leads to diminished collagen cross-linking and reduced collagen deposition in extracellular matrix.

Authors:  Aileen M Barnes; Wayne A Cabral; MaryAnn Weis; Elena Makareeva; Edward L Mertz; Sergey Leikin; David Eyre; Carlos Trujillo; Joan C Marini
Journal:  Hum Mutat       Date:  2012-07-16       Impact factor: 4.878

5.  Novel mutations in FKBP10 in Chinese patients with osteogenesis imperfecta and their treatment with zoledronic acid.

Authors:  Xiao-Jie Xu; Fang Lv; Yi Liu; Jian-Yi Wang; Dou-Dou Ma; Jia-Wei Wang; Li-Jie Song; Yan Jiang; Ou Wang; Wei-Bo Xia; Xiao-Ping Xing; Mei Li
Journal:  J Hum Genet       Date:  2016-08-25       Impact factor: 3.172

6.  Kuskokwim syndrome, a recessive congenital contracture disorder, extends the phenotype of FKBP10 mutations.

Authors:  Aileen M Barnes; Geraldine Duncan; Maryann Weis; William Paton; Wayne A Cabral; Edward L Mertz; Elena Makareeva; Michael J Gambello; Felicitas L Lacbawan; Sergey Leikin; Andrzej Fertala; David R Eyre; Sherri J Bale; Joan C Marini
Journal:  Hum Mutat       Date:  2013-07-08       Impact factor: 4.878

7.  Disentangling mechanisms involved in collagen pyridinoline cross-linking: The immunophilin FKBP65 is critical for dimerization of lysyl hydroxylase 2.

Authors:  Rutger A F Gjaltema; Miesje M van der Stoel; Miriam Boersema; Ruud A Bank
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-13       Impact factor: 11.205

8.  Homozygous sequence variants in the FKBP10 gene underlie osteogenesis imperfecta in consanguineous families.

Authors:  Muhammad Umair; Annum Hassan; Abid Jan; Farooq Ahmad; Muhammad Imran; Muhammad I Samman; Sulman Basit; Wasim Ahmad
Journal:  J Hum Genet       Date:  2015-11-05       Impact factor: 3.172

9.  Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines in bone collagen.

Authors:  Ulrike Schwarze; Tim Cundy; Shawna M Pyott; Helena E Christiansen; Madhuri R Hegde; Ruud A Bank; Gerard Pals; Arunkanth Ankala; Karen Conneely; Laurie Seaver; Suzanne M Yandow; Ellen Raney; Dusica Babovic-Vuksanovic; Joan Stoler; Ziva Ben-Neriah; Reeval Segel; Sari Lieberman; Liesbeth Siderius; Aida Al-Aqeel; Mark Hannibal; Louanne Hudgins; Elizabeth McPherson; Michele Clemens; Michael D Sussman; Robert D Steiner; John Mahan; Rosemarie Smith; Kwame Anyane-Yeboa; Julia Wynn; Karen Chong; Tami Uster; Salim Aftimos; V Reid Sutton; Elaine C Davis; Lammy S Kim; Mary Ann Weis; David Eyre; Peter H Byers
Journal:  Hum Mol Genet       Date:  2012-09-04       Impact factor: 6.150

10.  Long-Term Follow-Up Outcomes of 19 Patients with Osteogenesis Imperfecta Type XI and Bruck Syndrome Type I Caused by FKBP10 Variants.

Authors:  Aylin Yüksel Ülker; Dilek Uludağ Alkaya; Leyla Elkanova; Ali Şeker; Evren Akpınar; Nurten Ayşe Akarsu; Zehra Oya Uyguner; Beyhan Tüysüz
Journal:  Calcif Tissue Int       Date:  2021-06-25       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.